Jump to content

Andrew Teschendorff

Add links
From Wikipedia, the free encyclopedia
Andrew E. Teschendorff
NationalityBritish
Occupation(s)Researcher and an academic
Academic background
EducationB.Sc. (Honors) Mathematical physics
Certificate of Advanced Study in Mathematics (Part III)
Ph.D., Theoretical particle physics
Alma materUniversity of Edinburgh
University of Cambridge
Academic work
InstitutionsCAS Key Lab of Computational Biology

Andrew E. Teschendorff is a British researcher and an academic. He is professor and principal investigator at the CAS Key Lab of Computational Biology, which is part of the CAS Institute for Nutrition and Health, Shanghai.

Teschendorff's research has contributed towards the development of computational and statistical methods to help analyze and interpret complex multi-omic data, with a particular emphasis on single-cell omic and epigenomic applications in a systems biology context. He has been a recipient of the Heller Research Fellowship, Cambridge-MIT fellowship, and an Advanced International Newton Fellowship from the Royal Society. In 2023, he was a recipient of a Highly Cited Researcher award from Clarivate.

Education

[edit]

Teschendorff completed a B.Sc. (Honors) in Mathematical physics from the University of Edinburgh in 1995 with first-class honors, receiving the Tait Medal.[1] In 1996, he obtained a distinction in the Certificate of Advanced Study in Mathematics from the University of Cambridge. Later, in 2000, he earned a Ph.D. in Theoretical particle physics from the University of Cambridge. He performed post-doctoral work at the Breast Cancer Functional Genomics Laboratory at the University of Cambridge from 2003 to 2008.[2]

Career

[edit]

Teschendorff was a member of the Research Group at British Telecom Labs from 2000 to 2001 before joining the University of Warwick as a research assistant within the Mathematical Biology Group, where he remained from 2001 to 2003. He was a senior post-doctoral fellow in Computational Biology at the University of Cambridge between 2003 and 2008. In 2008, he joined University College London where he held the positions of principal research associate in Statistical Cancer Genomics until 2013, as well as Newton Advanced Fellow from 2015 to 2018. He then joined the CAS Max-Planck Partner Institute of Computational Biology in Shanghai, where he was a professor in Computational Systems Epigenomics from 2013 to 2020.[3] Since 2020, he has been a professor and principal investigator at CAS Key Lab of Computational Biology in Shanghai, and in 2015, was named an honorary research fellow at University College London.[4]

Research

[edit]

While at Cambridge, Teschendorff's bioinformatics work demonstrated the importance of immune-cell infiltration as a significant determinant of clinical outcome in estrogen receptor negative (ER-) breast cancer.[5] His computational methods demonstrated how specific ER binding patterns in estrogen receptor positive (ER+) breast cancer can influence the chance of a tumor undergoing metastasis.[6] He was part of a research team that identified an age-associated DNA methylation signature that appeared consistently across different normal tissue types and was enriched for polycomb group (PCG) target genes.[7]

In subsequent work, he proposed the concept of differential variability to identify cancer risk markers from DNA methylation measurements taken in precancerous lesions using the EVORA and iEVORA algorithms, and demonstrated how the DNA methylation outliers detected from these algorithms can discriminate histologically normal-tissue at cancer-risk from normal healthy tissue.[8] Building on the hypothesis that the cumulative number of stem-cell divisions in a tissue is a determinant of cancer risk, he then built the first epigenetic mitotic clock (epiTOC), showing how DNA methylation changes can be used to track the mitotic age of a tissue which could, in principle, be used for monitoring cancer-risk.[9]

Teschendorff has also explored physics-based approaches for analysing complex single-cell omic data, proposing the concept of signaling network entropy (Single-Cell Entropy-SCENT) as a means of estimating differentiation potency and cellular plasticity from single-cell RNA-Seq data.[10][11] Building upon the same framework, he subsequently developed the SCIRA algorithm to infer stemness at single-cell resolution from single-cell or single-nucleus RNA-Seq data.[12]

Teschendorff has also developed Beta Mixture Quantile dilation (BMIQ) algorithm[13] and the EpiDISH cell-type deconvolution framework.[14] Alongside colleagues, he is also a co-developer of the integrated analysis pipeline package, named Chip Analysis Methylation Pipeline (ChAMP), which offers a toolkit for analysing EWAS data.[15]

Awards and honors

[edit]
  • 1994 – Tait Medal, University of Edinburgh[1]
  • 2003 – Cambridge-MIT Initiative Fellowship[16]
  • 2005 – Isaac Newton Trust Fellowship, Isaac Newton Trust[17]
  • 2008 – Heller Research Fellowship, University College London[18]
  • 2015 – Newton Advanced Fellowship, The Royal Society[19]
  • 2019 – Excellent Teachers Award, CAS[3]
  • 2023 – Highly Cited Researcher Award, Clarivate[20]

Selected articles

[edit]

References

[edit]
  1. ^ a b "Tait Medalists". The University of Edinburgh. Retrieved May 8, 2025.
  2. ^ "Andrew E. Teschendorff". Shanghai Institute of Nutrition and Health. Retrieved May 8, 2025.
  3. ^ a b "Andrew Teschendorff". University of Chinese Academy of Sciences. Retrieved May 28, 2025.
  4. ^ "Andrew E. Teschendorff". Shanghai Institute of Nutrition and Health. Retrieved May 9, 2025.
  5. ^ Dannenfelser, Ruth; Nome, Marianne; Tahiri, Andliena; Ursini-Siegel, Josie; Vollan, Hans Kristian Moen; Haakensen, Vilde D.; Helland, Åslaug; Naume, Bjørn; Caldas, Carlos; Børresen-Dale, Anne-Lise; Kristensen, Vessela N.; Troyanskaya, Olga G. (22 August 2017). "Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity". Oncotarget. 8 (34): 57121–57133. doi:10.18632/oncotarget.19078. PMC 5593630. PMID 28915659.
  6. ^ Salmans, Michael L; Zhao, Fang; Andersen, Bogi (April 2013). "The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker". Breast Cancer Research. 15 (2): 204. doi:10.1186/bcr3408. PMC 3672732. PMID 23635006.
  7. ^ Dozmorov, Mikhail G (3 June 2015). "Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes". Epigenetics. 10 (6): 484–495. doi:10.1080/15592294.2015.1040619. PMC 4623031. PMID 25880792.
  8. ^ Saddiki, Hachem; Colicino, Elena; Lesseur, Corina (30 August 2022). "Assessing Differential Variability of High-Throughput DNA Methylation Data". Current Environmental Health Reports. 9 (4): 625–630. Bibcode:2022CEHR....9..625S. doi:10.1007/s40572-022-00374-4. PMC 11674072. PMID 36040576.
  9. ^ Martín Herranz, Daniel Elías (10 April 2019). "On the epigenetic ageing clock in humans". doi:10.17863/CAM.44841. {{cite journal}}: Cite journal requires |journal= (help)
  10. ^ Zhang, Feng; Yang, Chen; Wang, Yihao; Jiao, Huiyuan; Wang, Zhiming; Shen, Jianfeng; Li, Lingjie (20 September 2022). "FitDevo: accurate inference of single-cell developmental potential using sample-specific gene weight". Briefings in Bioinformatics. 23 (5). doi:10.1093/bib/bbac293. PMC 9487676. PMID 35870444.
  11. ^ Beisang, Daniel J.; Smith, Karen; Yang, Libang; Benyumov, Alexey; Gilbertsen, Adam; Herrera, Jeremy; Lock, Eric; Racila, Emilian; Forster, Colleen; Sandri, Brian J.; Henke, Craig A.; Bitterman, Peter B. (7 July 2020). "Single-cell RNA sequencing reveals that lung mesenchymal progenitor cells in IPF exhibit pathological features early in their differentiation trajectory". Scientific Reports. 10 (1): 11162. Bibcode:2020NatSR..1011162B. doi:10.1038/s41598-020-66630-5. PMC 7341888. PMID 32636398.
  12. ^ Hecker, Dennis; Lauber, Michael; Behjati Ardakani, Fatemeh; Ashrafiyan, Shamim; Manz, Quirin; Kersting, Johannes; Hoffmann, Markus; Schulz, Marcel H.; List, Markus (December 2023). "Computational tools for inferring transcription factor activity". Proteomics. 23 (23–24): e2200462. doi:10.1002/pmic.202200462. PMID 37706624.
  13. ^ Wang, Ting; Guan, Weihua; Lin, Jerome; Boutaoui, Nadia; Canino, Glorisa; Luo, Jianhua; Celedón, Juan Carlos; Chen, Wei (3 July 2015). "A systematic study of normalization methods for Infinium 450K methylation data using whole-genome bisulfite sequencing data". Epigenetics. 10 (7): 662–669. doi:10.1080/15592294.2015.1057384. PMC 4623491. PMID 26036609.
  14. ^ Zhang, Hanyu; Cai, Ruoyi; Dai, James; Sun, Wei (11 March 2021). "EMeth: An EM algorithm for cell type decomposition based on DNA methylation data". Scientific Reports. 11 (1): 5717. Bibcode:2021NatSR..11.5717Z. doi:10.1038/s41598-021-84864-9. PMC 7952399. PMID 33707472.
  15. ^ Muthamilselvan, Sangeetha; Raghavendran, Abirami; Palaniappan, Ashok (24 February 2022). "Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression". PLOS ONE. 17 (2): e0249151. Bibcode:2022PLoSO..1749151M. doi:10.1371/journal.pone.0249151. PMC 8870460. PMID 35202405.
  16. ^ "Andrew Teschendorff". Open access government. Retrieved May 28, 2025.
  17. ^ "Andrew E Teschendorff：Epigenetic Clocks, Aging and Cancer". East China Normal University. Retrieved May 28, 2025.
  18. ^ "Prof. Andrew E. Teschendorff". ICBMS. Retrieved May 8, 2025.
  19. ^ "First recipients of prestigious Newton Advanced Fellowships announced". The Royal Society. Retrieved May 8, 2025.
  20. ^ "769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023". MDPI. Retrieved May 8, 2025.
[edit]

Andrew Teschendorff publications indexed by Google Scholar

Retrieved from "https://en.wikipedia.org/w/index.php?title=Andrew_Teschendorff&oldid=1297211334"